Michael Donovan

8.3k total citations · 4 hit papers
137 papers, 4.9k citations indexed

About

Michael Donovan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael Donovan has authored 137 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 43 papers in Pulmonary and Respiratory Medicine and 26 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael Donovan's work include Prostate Cancer Diagnosis and Treatment (25 papers), Prostate Cancer Treatment and Research (25 papers) and Radiomics and Machine Learning in Medical Imaging (21 papers). Michael Donovan is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (25 papers), Prostate Cancer Treatment and Research (25 papers) and Radiomics and Machine Learning in Medical Imaging (21 papers). Michael Donovan collaborates with scholars based in United States, China and United Kingdom. Michael Donovan's co-authors include Weihong Tan, Jian‐Hui Jiang, Guizhi Zhu, Johan Skog, Mikkel Noerholm, Erqun Song, James M. McKiernan, Gordon Brown, Kejing Zhang and Jing Zheng and has published in prestigious journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Michael Donovan

125 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aptamers from Cell-Based Selection for Bioanalytical Applications

2013 568 citations Michael Donovan et al. profile →
A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy

2016 489 citations James M. McKiernan, Michael Donovan et al. profile →
Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranostics

2013 485 citations Michael Donovan et al. profile →
A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2–10 ng/ml at Initial Biopsy

2018 209 citations James M. McKiernan, Michael Donovan et al. profile →

Peers

Countries citing papers authored by Michael Donovan

Since Specialization

Citations

This map shows the geographic impact of Michael Donovan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Donovan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Donovan more than expected).

Fields of papers citing papers by Michael Donovan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Donovan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Donovan. The network helps show where Michael Donovan may publish in the future.

Co-authorship network of co-authors of Michael Donovan

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Donovan. A scholar is included among the top collaborators of Michael Donovan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Donovan. Michael Donovan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Advances in Targeted Therapy for Non-Small-Cell Lung Cancer: Current Progress and Future Directions 2025 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), John A. Couch, Michael Donovan, (unknown)	0
2	U.S. payer budget impact of using an AI-augmented cancer risk discrimination digital histopathology platform to identify high-risk of recurrence in women with early-stage invasive breast cancer 2024 ·Journal of Medical Economics ·Salwa Masud, (unknown), Thomas F. Goss, (unknown), Stuart J. Schnitt, Joseph A. Sparano, Michael Donovan	0
3	A Real-World Precision Medicine Program Including the KidneyIntelX Test Effectively Changes Management Decisions and Outcomes for Patients With Early-Stage Diabetic Kidney Disease 2024 ·Journal of Primary Care & Community Health ·(unknown), David W. Lam, (unknown), Stephanie Wang, (unknown), (unknown), Nidhi Naik, (unknown), (unknown), Azadeh Zabetian, Catherine Liu, (unknown), (unknown), (unknown), Steven G. Coca, Girish N. Nadkarni, (unknown), Michael W. Kattan, Michael Donovan, (unknown)	5
4	Cost-effectiveness analysis of LungLB for the clinical management of patients with indeterminate pulmonary nodules 2023 ·Journal of Medical Economics ·John E. Schneider, (unknown), (unknown), (unknown), Paul C. Pagano, David Anderson, Michael Donovan	1
5	Analytical Validation of the PreciseDx Digital Prognostic Breast Cancer Test in Early-Stage Breast Cancer 2023 ·Clinical Breast Cancer ·Gerardo Fernández, Jack Zeineh, Marcel Prastawa, (unknown), (unknown), Alexander Shtabsky, Shabnam Jaffer, (unknown), Brandon Veremis, (unknown), Elizabeth Charytonowicz, Nataliya Gladoun, (unknown), (unknown), (unknown), Michael Donovan	2
6	ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer – an interim analysis 2023 ·Prostate Cancer and Prostatic Diseases ·Ronald Tutrone, (unknown), (unknown), Michael Donovan, (unknown), (unknown), Yiyuan Yao, (unknown), Sonia Kumar, (unknown), Grannum R. Sant, Jason Alter, Johan Skog	33
7	NF2 mutation associated with accelerated time to recurrence for older patients with atypical meningiomas 2023 ·British Journal of Neurosurgery ·(unknown), (unknown), (unknown), John W. Rutland, Corey M. Gill, Ethan Ellis, Yayoi Kinoshita, Russell B. McBride, Joshua B. Bederson, Michael Donovan, Robert Sebra, Melissa Umphlett, Raj Shrivastava	1
8	Association of mutations in DNA polymerase epsilon with increased CD8+ cell infiltration and prolonged progression-free survival in patients with meningiomas 2022 ·Neurosurgical FOCUS ·John W. Rutland, (unknown), Corey M. Gill, (unknown), Daniel Ranti, Ethan Ellis, Annie E. Arrighi‐Allisan, Yayoi Kinoshita, Russell B. McBride, Joshua B. Bederson, Michael Donovan, Robert Sebra, Mary Fowkes, Melissa Umphlett, Raj Shrivastava	5
9	Real World Evidence and Clinical Utility of KidneyIntelX on Patients With Early-Stage Diabetic Kidney Disease: Interim Results on Decision Impact and Outcomes 2022 ·Journal of Primary Care & Community Health ·(unknown), (unknown), (unknown), Nidhi Naik, (unknown), (unknown), Stephanie Wang, (unknown), Azadeh Zabetian, Steven G. Coca, Girish N. Nadkarni, (unknown), Michael Donovan, (unknown)	4
10	Development and validation of an AI-enabled digital breast cancer assay to predict early-stage breast cancer recurrence within 6 years 2022 ·Breast Cancer Research ·Gerardo Fernández, Marcel Prastawa, (unknown), (unknown), Bahram Marami, (unknown), (unknown), (unknown), Monica S. M. Chan, (unknown), Alexander Shtabsky, (unknown), Thomas van Overeem Hansen, Brandon Veremis, Carlos Cordon‐Cardo, Jack Zeineh, Michael Donovan	14
11	Analytical validation of a multi-biomarker algorithmic test for prediction of progressive kidney function decline in patients with early-stage kidney disease 2021 ·Clinical Proteomics ·Patricia Connolly, (unknown), Gohar Mosoyan, (unknown), (unknown), (unknown), Michael Donovan	10
12	Derivation and validation of a machine learning risk score using biomarker and electronic patient data to predict progression of diabetic kidney disease 2021 ·Diabetologia ·Lili Chan, Girish N. Nadkarni, (unknown), James R. McCullough, Patricia Connolly, Gohar Mosoyan, Fadi Salem, Michael W. Kattan, Joseph A. Vassalotti, Barbara Murphy, Michael Donovan, Steven G. Coca, Scott M. Damrauer	92
13	Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies 2021 ·Prostate Cancer and Prostatic Diseases ·(unknown), Gordon Brown, Alan W. Partin, Ballentine Carter, James M. McKiernan, Ronald Tutrone, Phillipp Torkler, Christian Fischer, Vasisht Tadigotla, Mikkel Noerholm, Michael Donovan, Johan Skog	66
14	A urine-based Exosomal gene expression test stratifies risk of high-grade prostate Cancer in men with prior negative prostate biopsy undergoing repeat biopsy 2020 ·BMC Urology ·James M. McKiernan, Mikkel Noerholm, Vasisht Tadigotla, Sonia Kumar, Phillipp Torkler, Grannum R. Sant, Jason Alter, Michael Donovan, Johan Skog	35
15	Prostate Cancer in World Trade Center Responders Demonstrates Evidence of an Inflammatory Cascade 2019 ·Molecular Cancer Research ·Yixuan Gong, Li Wang, (unknown), Naomi Alpert, Mitchell D. Cohen, Colette Prophete, Lori Horton, (unknown), Sung‐Hyun Park, (unknown), Judith T. Zelikoff, Lung‐Chi Chen, Dana Hashim, Mayte Suárez‐Fariñas, Michael Donovan, Stuart A. Aaronson, Matthew D. Galsky, Jun Zhu, Emanuela Taioli, William Oh	20
16	Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial 2018 ·Clinical Cancer Research ·Chrisann Kyi, Vladimir Roudko, Rachel Lubong Sabado, Yvonne M. Saenger, (unknown), John Mandeli, Tin Htwe Thin, Deborah Lehrer, Michael Donovan, Marshall R. Posner, Krzysztof Misiukiewicz, Benjamin D. Greenbaum, Andres Μ. Salazar, Philip Friedlander, Nina Bhardwaj	97
17	Implementation of a Precision Pathology Program Focused on Oncology-Based Prognostic and Predictive Outcomes 2016 ·Molecular Diagnosis & Therapy ·Michael Donovan, Carlos Cordon‐Cardo	8
18	Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer 2014 ·Molecular Cancer Therapeutics ·Mercedes Marín‐Aguilera, Jordi Codony‐Servat, Òscar Reig, Juan José Lozano, Pedro L. Fernández, (unknown), Natàlia Jiménez, Michael Donovan, Pere Puig, Lourdes Mengual, Raquel Bermudo, Albert Font, Enrique Gallardo, María J. Ribal, Antonio Alcaraz, Pere Gascón, Begoña Mellado	123
19	Chronic Activation of Wild-Type Epidermal Growth Factor Receptor and Loss of Cdkn2a Cause Mouse Glioblastoma Formation 2011 ·Cancer Research ·Jaime Acquaviva, (unknown), Julie Lessard, (unknown), Huijun Zhu, Michael Donovan, Steve Woolfenden, Abraham Boskovitz, Ami P. Raval, Rod T. Bronson, Rolf Pfannl, Charles A. Whittaker, David E. Housman, Alain Charest	1
20	Cyclin D-1, Interleukin-6, HER-2/neu, Transforming Growth Factor Receptor-II and Prediction of Relapse in Women with Early Stage, Hormone Receptor-Positive Breast Cancer Treated with Tamoxifen 2007 ·The Breast Journal ·Hyman B. Muss, Janice Y. Bunn, Abigail Crocker, Karen Plaut, James Koh, (unknown), Mercedes Rincón, Donald L. Weaver, (unknown), Barbara Beatty, Peter A. Kaufman, Michael Donovan, David Verbel, (unknown)	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact